Form 8-K - Current report:
SEC Accession No. 0001193125-23-149905
Filing Date
2023-05-22
Accepted
2023-05-22 07:46:01
Documents
16
Period of Report
2023-05-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d475862d8k.htm   iXBRL 8-K 39203
2 EX-99.1 d475862dex991.htm EX-99.1 21074
3 EX-99.2 d475862dex992.htm EX-99.2 12398
7 GRAPHIC g475862g0520052105445.jpg GRAPHIC 3098
8 GRAPHIC g475862g0520052519545.jpg GRAPHIC 3098
  Complete submission text file 0001193125-23-149905.txt   217933

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20230519.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20230519_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20230519_pre.xml EX-101.PRE 10812
10 EXTRACTED XBRL INSTANCE DOCUMENT d475862d8k_htm.xml XML 3267
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 23942453
SIC: 2834 Pharmaceutical Preparations